| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
-17 |
| Equity
Latest Equity |
34.69 |
| Face Value
Latest Face Value |
2 |
| Reserves
Total Reserve |
1325.22 |
| Dividend
Full Year Dividend % |
60 |
| Sales Turnover
Full Year Net Sales |
947.32 |
| Net Profit
Full Year Net Profit |
247.82 |
| Full Year CPS
Full Year Cash Per Share |
15.7 |
| Earning Per Share
Full Year Earning Per Share |
14.3 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Mar 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
234.67 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
78.4 |
| Networth
Full Year Return on Networth |
30.85 |
| Price/Book Value
Price to Book value |
7.168367 |
| Yearly PE ratio
Full Year Price to Earning per share |
39.3 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
35.9 |
| Bse value
BSE Value in lakhs |
231.48 |
| Nse value
NSE Value in lakhs |
3945.39 |
| High
52 week high |
1028 |
| Low
52 week low |
325 |
| Price
NSE Current market price |
563 |
| CPM
Current market price |
562 |
| Market cap
BSE / NSE Market Cap |
9746.15 |
| Net profit
Latest Quarter Net Profit |
64.34 |
| Net profit variance
Latest Quarter Net Profit variance |
-42 |
| Result year
Trailing latest month |
Mar 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
721.86 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
211.66 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
29.32 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
356.51 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
37.63 |
| TTM NP
Trailing Twelve 12 month Net Profit |
174.82 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
-17.16 |
| TTM EPS
Trailing Twelve 12 month EPS |
14.29 |
| TTM PE
Trailing Twelve 12 month PE |
39.32 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
23.67 |
| Equity
Latest Equity |
34.69 |
| LTP
Latest Price (BSE/NSE) |
562 |
| Gross block
Latest Gross Block |
420.87 |
| Loans
Total loans |
21.49 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
31 |
| Year GPM
Full Year Gross Profit Margin |
37.6 |
| Quarter OPM
Latest quater Operation Profit Margin |
30.4 |
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 163 | 208 | 318 | 340 | 355 | 165 | 192 | 235 |
| YOY Sales Growth % | -9% | 15% | 91% | 85% | 118% | -21% | -40% | -31% |
| Gross Sales | 163 | 208 | 318 | 340 | 355 | 165 | 192 | 235 |
| + Expenses | 119 | 139 | 194 | 200 | 234 | 111 | 146 | 163 |
| Material Cost % | 66% | 67% | 62% | 51% | 9% | 96% | 34% | 36% |
| Raw Material Cost | 91 | 115 | 171 | 163 | 108 | 108 | 79 | 93 |
| Change in Inventory | 17 | 25 | 27 | 10 | -75 | 51 | -14 | -9 |
| Manufacturing Cost % | 18% | 16% | 11% | 9% | 9% | 21% | 17% | 18% |
| Employee Cost % | 9% | 7% | 5% | 5% | 5% | 11% | 10% | 8% |
| Other Cost % | -21% | -24% | -17% | -6% | 42% | -61% | 14% | 8% |
| Raw Materials % | 56% | 55% | 54% | 48% | 30% | 66% | 41% | 40% |
| Stock Adjustments % | -10% | -12% | -8% | -3% | 21% | -31% | 7% | 4% |
| Other Manufacturing Expenses % | 18% | 16% | 11% | 9% | 9% | 21% | 17% | 18% |
| Operating Profit | 44 | 69 | 124 | 140 | 121 | 55 | 47 | 71 |
| OPM % | 27% | 33% | 39% | 41% | 34% | 33% | 24% | 30% |
| + Other Income | 9 | 12 | 13 | 12 | 8 | 24 | 13 | 23 |
| Miscellaneous Income | 9 | 12 | 13 | 12 | 8 | 24 | 13 | 23 |
| Interest | 0 | 0 | 0 | 0 | 1 | 5 | 0 | 1 |
| Depreciation | 3 | 5 | 5 | 5 | 6 | 6 | 6 | 6 |
| Profit before tax | 49 | 77 | 132 | 147 | 123 | 69 | 54 | 87 |
| + Tax % | 24% | 24% | 25% | 25% | 26% | 24% | 25% | 26% |
| Current Tax | 10 | 18 | 33 | 37 | 30 | 18 | 12 | 22 |
| Deferred Tax | 2 | 1 | 1 | 0 | 2 | -1 | 2 | 1 |
| Net Profit | 38 | 58 | 99 | 110 | 91 | 52 | 40 | 64 |
| EPS in Rs |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| + Sales | 538 | 499 | 683 | 721 | 712 | 1,030 |
| Sales Growth % | -7% | 37% | 5% | -1% | 45% | |
| Gross Sales | 721 | 712 | 1,030 | |||
| + Expenses | 277 | 388 | 427 | 502 | 492 | 652 |
| Material Cost % | 39% | 34% | 42% | 47% | 44% | 45% |
| Raw Material Cost | 187 | 214 | 284 | 350 | 304 | 540 |
| Change in Inventory | 24 | -45 | 4 | -14 | 10 | -79 |
| Manufacturing Cost % | 8% | 10% | 9% | 9% | 8% | 7% |
| Employee Cost % | 4% | 6% | 5% | 6% | 7% | 6% |
| Other Cost % | -0% | 28% | 7% | 8% | 9% | 6% |
| Raw Materials % | 35% | 43% | 42% | 49% | 43% | 52% |
| Stock Adjustments % | -4% | 9% | -1% | 2% | -1% | 8% |
| Power & Fuel % | 4% | 4% | 4% | 5% | 3% | 2% |
| Other Manufacturing Expenses % | 5% | 6% | 5% | 5% | 5% | 4% |
| Selling & Administration % | 6% | 7% | 6% | 6% | 5% | 4% |
| Miscellaneous Expenses % | 2% | 3% | 2% | 2% | 4% | 2% |
| Operating Profit | 261 | 111 | 257 | 219 | 219 | 378 |
| OPM % | 49% | 22% | 38% | 30% | 31% | 37% |
| + Other Income | 6 | 9 | 19 | 24 | 29 | 46 |
| Miscellaneous Income | 24 | 29 | 46 | |||
| Interest | 7 | 5 | 3 | 1 | 0 | 0 |
| Depreciation | 18 | 20 | 22 | 25 | 28 | 18 |
| Profit before tax | 217 | 220 | 406 | |||
| + Tax % | 26% | 26% | 25% | |||
| Current Tax | 52 | 46 | 63 | 56 | 54 | 97 |
| Deferred Tax | -3 | 3 | -1 | 1 | 2 | 4 |
| + Net Profit | 160 | 164 | 305 | |||
| Profit Growth % | 2% | 86% | ||||
| Extraordinary Income / Expense | 0 | -10 | 0 | |||
| Exceptional Item | 0 | -10 | 0 | |||
| Minority Interest (After Tax) | 0 | 3 | 0 | 0 | 0 | 0 |
| Net Profit After Minority Interest | 145 | 138 | 0 | 0 | 0 | 0 |
| EPS in Rs | 24,159.67 | 1,369.93 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1 | 10 | 35 | 35 | 35 | 35 |
| Reserves | 182 | 320 | 487 | 647 | 811 | 1,098 |
| + Borrowings | 79 | 53 | 19 | 5 | 3 | 21 |
| Secured Borrowings | 60 | 48 | 0 | 0 | 0 | 0 |
| Unsecured Borrowings | 19 | 5 | 19 | 5 | 3 | 21 |
| + Other Liabilities | 114 | 153 | 173 | 176 | 211 | 263 |
| Current Liabilities | 91 | 141 | 171 | 173 | 208 | 260 |
| Provisions | 5 | 50 | 86 | 81 | 125 | 133 |
| Minority Interest | 1 | 0 | 0 | 0 | 0 | 0 |
| Equity Application Money | 19 | 10 | 0 | 0 | 0 | 0 |
| Other liability items | 2 | 3 | 4 | 4 | 4 | 5 |
| Total Liabilities | 375 | 536 | 713 | 862 | 1,059 | 1,418 |
| + Fixed Assets | 107 | 139 | 156 | 151 | 172 | 300 |
| Gross Block | 125 | 177 | 215 | 231 | 276 | 421 |
| Accumulated Depreciation | 18 | 38 | 58 | 80 | 104 | 121 |
| CWIP | 2 | 3 | 3 | 30 | 147 | 89 |
| Investments | 34 | 37 | 94 | 189 | 250 | 187 |
| + Other Assets | 233 | 358 | 460 | 491 | 489 | 841 |
| Inventories | 69 | 118 | 105 | 126 | 130 | 264 |
| Trade receivables | 118 | 144 | 227 | 239 | 177 | 350 |
| Cash Equivalents | 15 | 70 | 88 | 66 | 85 | 120 |
| Loans n Advances | 22 | 22 | 36 | 47 | 80 | 88 |
| Other asset items | 7 | 4 | 4 | 14 | 17 | 20 |
| Total Assets | 375 | 536 | 713 | 862 | 1,059 | 1,418 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 123 | 129 | 146 | 142 | 241 | 46 |
| Profit from Operations | 233 | 202 | ||||
| Working Capital Changes | -61 | -73 | ||||
| Profit Before Tax & Extraordinary Items | 194 | 185 | 243 | 217 | 220 | 406 |
| Depreciation | 18 | 20 | 22 | 25 | 28 | 18 |
| Interest (Net) | 7 | 5 | 3 | 1 | -2 | -5 |
| Profit / Loss on Sale of Assets | 0 | 0 | 0 | 0 | 6 | 0 |
| Profit / Loss on Sale of Investments | 0 | -3 | -2 | -7 | -14 | -18 |
| Provisions & Write-offs (Net) | 0 | 1 | 0 | 1 | 3 | 2 |
| Profit / Loss in Forex | 9 | -5 | -17 | -2 | -2 | -5 |
| Receivables | -101 | -24 | -66 | -10 | 64 | -170 |
| Inventories | 2 | -49 | 13 | -21 | -4 | -134 |
| Trade Payables | 32 | 5 | -4 | -3 | -13 | 48 |
| Direct Taxes Paid | -49 | 0 | -28 | -60 | -11 | -89 |
| + Cash from Investing Activity | -45 | -51 | -76 | -147 | -264 | -35 |
| Purchase of Fixed Assets | -16 | -49 | -23 | -59 | -174 | -80 |
| Sale of Fixed Assets | 0 | 0 | 1 | 0 | 1 | 0 |
| Purchase of Investments | -71 | -10 | -55 | -111 | -86 | -85 |
| Sale of Investments | 41 | 8 | 0 | 23 | 39 | 167 |
| Interest Received | 0 | 1 | 0 | 0 | 0 | 5 |
| Others | 0 | 0 | 0 | 0 | -44 | -43 |
| + Cash from Financing Activity | -73 | -28 | -56 | -4 | -2 | -19 |
| Repayment of Long-Term Borrowings | -65 | -22 | -53 | 0 | 0 | 0 |
| Repayment of Financial Liabilities | 0 | 0 | 0 | -3 | -2 | -1 |
| Dividend Paid | 0 | 0 | 0 | 0 | 0 | -17 |
| Interest Paid | -7 | -5 | ||||
| Net Cash Flow | 5 | 51 | 14 | -10 | -24 | -8 |